Condition

Diffuse Large B Cell Lymphoma Refractory clinical trials and research

• 8Clinical trials
• 7Countries

Newest Diffuse Large B Cell Lymphoma Refractory clinical trials

All recruiting trials (8)

• Radiation, Vancomycin, and CAR-T for B-Cell Lymphoma

  This trial tests if giving radiation and the antibiotic vancomycin before CAR-T cell therapy is feasible for adults with large B-cell lymphomas.

  Recruiting Phase 1 Abramson Cancer Center at Penn Medicine · Philadelphia, Pennsylvania · NCT07478848

• Glofitamab as a Bridge to and/or Consolidation After Stem Cell Transplant for Relapsed or Refractory B-Cell Lymphoma

  This trial tests glofitamab in adults with relapsed or refractory DLBCL to see if using it around autologous stem cell transplant helps or improves outcomes.

  Recruiting Phase 2 American University of Beirut Medical Center · Beirut · NCT07387848

• Ronde-cel versus standard CD19 CAR T‑cell therapy for relapsed or refractory large B‑cell lymphoma

  This test sees if ronde-cel, a CAR T therapy that targets both CD19 and CD20, works better than currently used CD19 CAR T therapies for adults whose large B‑cell lymphoma returned or did not respond after first‑line treatment.

  Recruiting at 41 sites Phase 3 Lyell Immunopharma, Inc. · Gilbert, Arizona and 43 other locations · NCT07188558

• VK-2019 for adults with relapsed or refractory EBV-positive diffuse large B‑cell lymphoma

  This trial tests daily oral VK-2019 in adults with relapsed or refractory EBV-positive DLBCL to see if it is safe and can control the disease.

  Recruiting Phase 1 University of Kentucky · Lexington, Kentucky · NCT06789159

• Evaluating GF-CART01 for treating relapsed or refractory B-cell cancers

  This study is testing a new CAR T cell therapy called GF-CART01 to see if it can help adults with tough-to-treat B-cell cancers that haven't responded to other treatments.

  Recruiting Phase 1 GenomeFrontier Therapeutics TW Co., Ltd. · Taipei · NCT06703892

• Combining Glofitamab and Chidamide for treating recurrent DLBCL

  This study is testing if a combination of two medications, Glofitamab and Chidamide, can help adults with recurring diffuse large B-cell lymphoma feel better.

  Recruiting Phase 2 Tianjin Medical University Cancer Institute and Hospital · Tianjin, Tianjin Municipality · NCT06570447

• Golcadomide treatment after CAR T-cell therapy for aggressive large B-cell lymphoma

  This study is testing if golcadomide can help people with aggressive large B-cell lymphoma stay in remission after they receive CAR T-cell therapy.

  Recruiting at 13 sites Phase 2 The Lymphoma Academic Research Organisation · Créteil and 12 other locations · NCT06271057

• Combining CC-99282 with Rituximab for Non-Hodgkin's Lymphoma Treatment

  This study is testing a new combination of a pill called CC-99282 and an infusion called rituximab to see if it helps people with non-Hodgkin's lymphoma who didn't respond well to previous treatments.

  Recruiting Phase 1 Ohio State University Comprehensive Cancer Center · Columbus, Ohio · NCT06209619

Related topics

Quick answers

How many Diffuse Large B Cell Lymphoma Refractory clinical trials are recruiting right now?

8, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 7 countries. The most sites are in United States (4 trials), France (1 trial), Lebanon (1 trial), Australia (1 trial), Canada (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 4, Phase 2: 3, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →